{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:39:31Z","timestamp":1789087171638,"version":"build-2803163510"},"update-to":[{"DOI":"10.1371\/journal.pntd.0009697","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T00:00:00Z","timestamp":1631145600000}}],"reference-count":48,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T00:00:00Z","timestamp":1629072000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"uk aid","award":["Awarded to DNDi"],"award-info":[{"award-number":["Awarded to DNDi"]}]},{"name":"federal ministry of education and research (bmbf) through kfw","award":["Awarded to DNDi"],"award-info":[{"award-number":["Awarded to DNDi"]}]},{"name":"dutch ministry of foreign affairs (dgis), the netherlands","award":["Awarded to DNDi"],"award-info":[{"award-number":["Awarded to DNDi"]}]},{"name":"Swiss Agency for Development and Cooperation (SDC), Switzerland","award":["Awarded to DNDi"],"award-info":[{"award-number":["Awarded to DNDi"]}]},{"name":"M\u00e9decins Sans Fronti\u00e8res (Doctors without Borders) International","award":["Awarded to DNDi"],"award-info":[{"award-number":["Awarded to DNDi"]}]}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>Chagas disease (CD), caused by the parasite <jats:italic>Trypanosoma cruzi<\/jats:italic>, affects ~6\u20137 million people worldwide. Significant limitations still exist in our understanding of CD. Harnessing individual participant data (IPD) from studies could support more in-depth analyses to address the many outstanding research questions. This systematic review aims to describe the characteristics and treatment practices of clinical studies in CD and assess the breadth and availability of research data for the potential establishment of a data-sharing platform.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methodology\/Principal findings<\/jats:title>\n<jats:p>This review includes prospective CD clinical studies published after 1997 with patients receiving a trypanocidal treatment. The following electronic databases and clinical trial registry platforms were searched: Cochrane Library, PubMed, Embase, LILACS, Scielo, Clintrials.gov, and WHO ICTRP.<\/jats:p>\n<jats:p>Of the 11,966 unique citations screened, 109 (0.9%) studies (31 observational and 78 interventional) representing 23,116 patients were included. Diagnosis for patient enrolment required 1 positive test result in 5 (4.6%) studies (2 used molecular method, 1 used molecular and serology, 2 used serology and parasitological methods), 2 in 60 (55.0%), 3 in 14 (12.8%) and 4 or more in 4 (3.7%) studies. A description of treatment regimen was available for 19,199 (83.1%) patients, of whom 14,605 (76.1%) received an active treatment and 4,594 (23.9%) were assigned to a placebo\/no-treatment. Of the 14,605 patients who received an active treatment, benznidazole was administered in 12,467 (85.4%), nifurtimox in 825 (5.6%), itraconazole in 284 (1.9%), allopurinol in 251 (1.7%) and other drugs in 286 (1.9%). Assessment of efficacy varied largely and was based primarily on biological outcome; parasitological efficacy relied on serology in 67\/85 (78.8%) studies, molecular methods in 52\/85 (61.2%), parasitological in 34\/85 (40.0%), microscopy in 3\/85 (3.5%) and immunohistochemistry in 1\/85 (1.2%). The median time at which parasitological assessment was carried out was 79 days [interquartile range (IQR): 30\u2013180] for the first assessment, 180 days [IQR: 60\u2013500] for second, and 270 days [IQR: 18\u2013545] for the third assessment.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Conclusions\/Significance<\/jats:title>\n<jats:p>This review demonstrates the heterogeneity of clinical practice in CD treatment and in the conduct of clinical studies. The sheer volume of potential IPD identified demonstrates the potential for development of an IPD platform for CD and that such efforts would enable in-depth analyses to optimise the limited pharmacopoeia of CD and inform prospective data collection.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pntd.0009697","type":"journal-article","created":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T18:56:39Z","timestamp":1629140199000},"page":"e0009697","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":31,"title":["The Chagas disease study landscape: A systematic review of clinical and observational antiparasitic treatment studies to assess the potential for establishing an individual participant-level data platform"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6333-0109","authenticated-orcid":true,"given":"Brittany J.","family":"Maguire","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2158-846X","authenticated-orcid":true,"given":"Prabin","family":"Dahal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8657-9639","authenticated-orcid":true,"given":"Sumayyah","family":"Rashan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4417-0653","authenticated-orcid":true,"given":"Roland","family":"Ngu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7977-6511","authenticated-orcid":true,"given":"Anca","family":"Boon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1481-8367","authenticated-orcid":true,"given":"Colin","family":"Forsyth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9915-6934","authenticated-orcid":true,"given":"Nathalie","family":"Strub-Wourgaft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Chatelain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana","family":"Barreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Sosa-Estani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6008-2963","authenticated-orcid":true,"given":"Philippe J.","family":"Gu\u00e9rin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2021,8,16]]},"reference":[{"issue":"Supplement I","key":"pntd.0009697.ref001","article-title":"2nd Brazilian Consensus on Chagas disease, 2015","author":"JCP Dias","year":"2016","journal-title":"Rev da Soc Bras Med Trop 49"},{"key":"pntd.0009697.ref002","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.csbj.2016.12.002","article-title":"Chagas disease research and development: Is there light at the end of the tunnel?","volume":"14","author":"E Chatelain","year":"2017","journal-title":"Comput Struct Biotechnol J"},{"key":"pntd.0009697.ref003","article-title":"WHO fact sheet no. 340","author":"World Health Organization","year":"2016"},{"key":"pntd.0009697.ref004","doi-asserted-by":"crossref","first-page":"817","DOI":"10.3855\/jidc.2459","article-title":"Mortality due to Chagas disease in Brazil from 1979 to 2009: Trends and regional differences","volume":"6","author":"FR Martins-Melo","year":"2012","journal-title":"J Infect Dev Ctries"},{"key":"pntd.0009697.ref005","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1590\/0037-8682-0248-2013","article-title":"The present situation, challenges, and perspectives regarding the production and utilization of effective drugs against human Chagas disease.","volume":"47","author":"JCP Dias","year":"2014","journal-title":"Rev Soc Bras Med Trop"},{"key":"pntd.0009697.ref006","doi-asserted-by":"crossref","first-page":"6125","DOI":"10.1128\/AAC.04660-14","article-title":"Toxic profile of benznidazole in patients with chronic chagas disease: Risk factors and comparison of the product from two different manufacturers","volume":"59","author":"I Molina","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"pntd.0009697.ref007","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.4269\/ajtmh.15-0256","article-title":"Safety profile of nifurtimox and treatment interruption for chronic chagas disease in Colombian adults","volume":"93","author":"MJ Olivera","year":"2015","journal-title":"Am J Trop Med Hyg"},{"key":"pntd.0009697.ref008","doi-asserted-by":"crossref","first-page":"e3312","DOI":"10.1371\/journal.pntd.0003312","article-title":"Trypanocide Treatment of Women Infected with Trypanosoma cruzi and Its Effect on Preventing Congenital Chagas","volume":"8","author":"DL Fabbro","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0009697.ref009","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1590\/S0037-86822009000500002","article-title":"Etiological treatment of young women infected with Trypanosoma cruzi, and prevention of congenital transmission","volume":"42","author":"S Sosa-Estani","year":"2009","journal-title":"Rev Soc Bras Med Trop"},{"key":"pntd.0009697.ref010","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.actatropica.2017.07.004","article-title":"Prevention of congenital Chagas disease by Benznidazole treatment in reproductive-age women. An observational study","volume":"174","author":"MG \u00c1lvarez","year":"2017","journal-title":"Acta Trop"},{"key":"pntd.0009697.ref011","first-page":"CD004102","article-title":"Trypanocidal drugs for late stage, symptomatic Chagas disease (Trypanosoma cruzi infection)","author":"M Vallejo","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"pntd.0009697.ref012","first-page":"CD003463","article-title":"Trypanocidal drugs for chronic asymptomatic Trypanosoma cruzi infection.","volume":"2014","author":"JC Villar","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"pntd.0009697.ref013","doi-asserted-by":"crossref","first-page":"e0008529","DOI":"10.1371\/journal.pntd.0008529","article-title":"Fixed vs adjusted-dose benznidazole for adults with chronic chagas disease without cardiomyopathy: A systematic review and meta-analysis","volume":"14","author":"A Ciapponi","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0009697.ref014","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1177\/0163278702025001006","article-title":"To IPD or not to IPD? Advantages and disadvantages of systematic reviews using individual patient data","volume":"25","author":"LA Stewart","year":"2002","journal-title":"Eval Health Prof"},{"key":"pntd.0009697.ref015","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1136\/bmj.c221","article-title":"Meta-analysis of individual participant data: Rationale, conduct, and reporting","volume":"340","author":"RD Riley","year":"2010","journal-title":"BMJ"},{"key":"pntd.0009697.ref016","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijid.2018.05.019","article-title":"Course of serological tests in treated subjects with chronic Trypanosoma cruzi infection: A systematic review and meta-analysis of individual participant data","volume":"73","author":"Y Sguassero","year":"2018","journal-title":"Int J Infect Dis"},{"key":"pntd.0009697.ref017","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0008418","article-title":"A new patient registry for chagas disease","volume":"14","author":"P Hotez","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0009697.ref018","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.cub.2013.11.014","article-title":"The availability of research data declines rapidly with article age","volume":"24","author":"TH Vines","year":"2014","journal-title":"Curr Biol"},{"key":"pntd.0009697.ref019","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/annotation\/3db421e4-3e27-4442-8092-2ad1b778f371","article-title":"The Effect of Dosing Regimens on the Antimalarial Efficacy of Dihydroartemisinin-Piperaquine: A Pooled Analysis of Individual Patient Data","volume":"10","author":"WorldWide Antimalarial Resistance Network (WWARN) DP Study Group","year":"2013","journal-title":"PLoS Med"},{"key":"pntd.0009697.ref020","author":"World Health Organization","year":"2015","journal-title":"Guidelines for the Treatment of Malaria"},{"key":"pntd.0009697.ref021","doi-asserted-by":"crossref","first-page":"i5295","DOI":"10.1136\/bmj.i5295","article-title":"Beyond open data: realising the health benefits of sharing data","volume":"355","author":"E Pisani","year":"2016","journal-title":"BMJ"},{"key":"pntd.0009697.ref022","first-page":"1","article-title":"Population pharmacokinetic properties of piperaquine in falciparum malaria: An individual participant data meta-analysis","volume":"14","author":"RM Hoglund","year":"2017"},{"key":"pntd.0009697.ref023","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4269\/ajtmh.18-0649","article-title":"Strength in numbers: The WWARN case study of purpose-driven data sharing","volume":"100","author":"GS Humphreys","year":"2019","journal-title":"Am J Trop Med Hyg"},{"key":"pntd.0009697.ref024","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12916-015-0301-z","article-title":"The effect of dosing strategies on the therapeutic efficacy of artesunate-amodiaquine for uncomplicated malaria: a meta-analysis of individual patient data","volume":"13","author":"The WorldWide Antimalarial Resistance Network (WWARN) AS-AQ Study Group","year":"2015","journal-title":"BMC Med"},{"key":"pntd.0009697.ref025","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S1473-3099(15)70024-1","article-title":"The effect of dose on the antimalarial efficacy of artemether\u2013lumefantrine: a systematic review and pooled analysis of individual patient data","volume":"15","author":"Worldwide Antimalarial Resistance Network (WWARN) AL Dose Impact Study Group.","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"pntd.0009697.ref026","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s12916-015-0445-x","article-title":"Clinical determinants of early parasitological response to ACTs in African patients with uncomplicated falciparum malaria: a literature review and meta-analysis of individual patient data","volume":"13","author":"WWARN ACT Africa Baseline Study Group","year":"2015","journal-title":"BMC Med"},{"key":"pntd.0009697.ref027","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12916-016-0621-7","article-title":"Gametocyte carriage in uncomplicated Plasmodium falciparum malaria following treatment with artemisinin combination therapy: a systematic review and meta-analysis of individual patient data","volume":"14","author":"WWARN Gametocyte Study Group","year":"2016","journal-title":"BMC Med"},{"key":"pntd.0009697.ref028","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/S1473-3099(18)30348-7","article-title":"The effect of chloroquine dose and primaquine on Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient pooled meta-analysis","volume":"18","author":"RJ Commons","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"pntd.0009697.ref029","doi-asserted-by":"crossref","first-page":"e1002928","DOI":"10.1371\/journal.pmed.1002928","article-title":"The efficacy of dihydroartemisinin- piperaquine and artemether-lumefantrine with and without primaquine on Plasmodium vivax recurrence: A systematic review and individual patient data meta-analysis","volume":"16","author":"RJ Commons","year":"2019","journal-title":"PLoS Med"},{"key":"pntd.0009697.ref030","author":"Wellcome Trust","year":"2008","journal-title":"Sharing public health data: a code of conduct"},{"key":"pntd.0009697.ref031","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0140-6736(10)62234-9","article-title":"Sharing research data to improve public health","volume":"377","author":"M Walport","year":"2011","journal-title":"Lancet"},{"key":"pntd.0009697.ref032","author":"Institute of Medicine. Sharing Clinical Trial Data: Maximizing Benefits","year":"2015"},{"key":"pntd.0009697.ref033","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1056\/NEJMe1515172","article-title":"Sharing clinical trial data\u2014A proposal from the International Committee of Medical Journal Editors","volume":"374","author":"DB Taichman","year":"2016","journal-title":"N Engl J Med"},{"key":"pntd.0009697.ref034","unstructured":"European Medicines Agency. Policy on Publication of Clinical Data for Medicinal Products for Human Use (EMA\/144064\/2019). 2019. Available: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Other\/2014\/10\/WC500174796.pdf"},{"key":"pntd.0009697.ref035","unstructured":"European Commission. Commission Implementing Regulation 2016\/9 on joint submission of data and data-sharing (REACH). In: Official Journal of the European Union [Internet]. 2016 [cited 6 Aug 2021] pp. 41\u201345. Available: https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/PDF\/?uri=CELEX:32016R0009&from=IT"},{"key":"pntd.0009697.ref036","unstructured":"Chatham House: The Royal Institute of International Affairs. A guide to sharing the data and benefits of public health surveillance. 2016 [cited 6 Aug 2021]. Available: https:\/\/www.chathamhouse.org\/sites\/default\/files\/publications\/research\/2017-05-25-data-sharing-guide.pdf"},{"key":"pntd.0009697.ref037","unstructured":"Veritas Health Innovation. Covidence systematic review software.Melbourne, Australia. 2019 [cited 5 Aug 2021]. Available: www.covidence.org"},{"key":"pntd.0009697.ref038","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)-A metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"PA Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"pntd.0009697.ref039","doi-asserted-by":"crossref","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: Building an international community of software platform partner","volume":"95","author":"PA Harris","year":"2019","journal-title":"J Biomed Inform"},{"key":"pntd.0009697.ref040","first-page":"1","article-title":"The Schistosomiasis Clinical Trials Landscape: A Systematic Review of Antischistosomal Treatment Efficacy Studies and a Case for Sharing Individual Participant-Level Data (IPD).","volume":"10","author":"AM Jul\u00e9","year":"2016","journal-title":"PLoS Negl Trop Dis."},{"key":"pntd.0009697.ref041","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmj.h870","article-title":"Use of GRADE for assessment of evidence about prognosis: Rating confidence in estimates of event rates in broad categories of patients","volume":"350","author":"A Iorio","year":"2015","journal-title":"BMJ"},{"key":"pntd.0009697.ref042","article-title":"Chagas Fact Sheet. Chagas disease (also known as American trypanosomiasis).","author":"World Health Organization","year":"2020"},{"key":"pntd.0009697.ref043","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0139363","article-title":"Course of chronic Trypanosoma cruzi infection after treatment based on parasitological and serological tests: A systematic review of follow-up studies","volume":"10","author":"Y Sguassero","year":"2015","journal-title":"PLoS One"},{"key":"pntd.0009697.ref044","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0007786","article-title":"A call to action for universal health coverage: Why we need to address gender inequities in the neglected tropical diseases community","volume":"14","author":"K Ozano","year":"2020","journal-title":"PLoS Negl Trop Dis."},{"key":"pntd.0009697.ref045","doi-asserted-by":"crossref","first-page":"e0006602","DOI":"10.1371\/journal.pntd.0006602","article-title":"Scientometrics analysis of research activity and collaboration patterns in Chagas cardiomyopathy","volume":"12","author":"G Gonz\u00e1lez-Alcaide","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0009697.ref046","article-title":"To share or not to share: Publication and quality assurance of research data outputs","author":"A Swan","year":"2008","journal-title":"A report commissioned by the Research Information Network"},{"key":"pntd.0009697.ref047","doi-asserted-by":"crossref","first-page":"e1001603","DOI":"10.1371\/journal.pmed.1001603","article-title":"Living Systematic Reviews: An Emerging Opportunity to Narrow the Evidence-Practice Gap","volume":"11","author":"JH Elliott","year":"2014","journal-title":"PLoS Med"},{"key":"pntd.0009697.ref048","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jclinepi.2017.08.010","article-title":"Living systematic review: 1. Introduction\u2014the why, what, when, and how","volume":"91","author":"JH Elliott","year":"2017","journal-title":"J Clin Epidemiol"}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0009697","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T00:00:00Z","timestamp":1631145600000}}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0009697","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T20:06:05Z","timestamp":1631217965000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0009697"}},"subtitle":[],"editor":[{"given":"Jair Lage","family":"Siqueira-Neto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,8,16]]},"references-count":48,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,8,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0009697","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.pntd.0009697","asserted-by":"object"}]},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,16]]}}}